Skip to content

A clinical trial to study the effect of Shatapushpa Taila Nasya in two different phases of menstrual cycle in primary dysmenorrhea

A comparative clinical study to evaluate the efficacy of Shatapushpa Taila Nasya in Proliferative and Secretory phases of menstrual cycle in Udavarta Yonivyapat W.S.R. to Primary Dysmenorrhea. - NIL

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/06/068829
Enrollment
30
Registered
2024-06-12
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N944- Primary dysmenorrhea

Interventions

None listed

Sponsors

Dr Bhagyavathi S
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Women having the classical Lakshanas of Udavarta Yonivyapat and symptoms of Primary dysmenorrhea. 2. Women who are Nasya Yogya according to Ayurveda Classics irrespective of occupation and socio-economic status. 3. Women in between 12 years and 50 years of age.

Exclusion criteria

Exclusion criteria: 1. Women who are Nasya Ayogya according to Ayurveda Classics. 2. Patients with the association of other disorders like fibroid, endometriosis, PID etc. 3. Patients below age of 12 years and above 50 years.

Design outcomes

Primary

MeasureTime frame
1.WaLIDD Score for working ability, intensity of pain, duration of pain asssessment 2. Multidimensional scoring system of dysmenorrhea for assessment of severity of pain, systemic symptoms involvedTimepoint: 0th day, 1st cycle, 2nd cycle, 3rd menstrual cycle after Nasya Karma(Days cannot be specified as the menstrual cycle may varry between 28 to 35 days)

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Soumya S V

KVG Ayurveda Medical College and Hospital,

drsoumyasv@gmail.com9620283474

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026